Catalyst Pharmaceuticals (CPRX) - News Mentions

Sign up to add (CPRX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
BridgeBio Pharma
BridgeBio Pharma
BBIO		 0 100%
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
November 19
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
November 14
Truist Financial Issues Positive Forecast for Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price
November 13
Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work
November 12
Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point
November 12
Catalyst Pharmaceuticals (NASDAQ:CPRX) vs. Antibe Therapeutics (OTCMKTS:ATBPF) Critical Analysis
November 12
Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
November 10
US Bancorp DE Has $902,000 Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
November 9
Catalyst Pharmaceuticals Reports Strong Financial Results and Corporate Update
November 8
With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case
November 7
Catalyst Pharmaceuticals, Inc. (CPRX) Hit a 52 Week High, Can the Run Continue?
November 6
Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript
November 6
Catalyst (CPRX) Reports Q3 Earnings: What Key Metrics Have to Say
November 6
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
November 6
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
November 6
Catalyst Pharmaceuticals : Reports Q3 2024 Total Revenues of $128.7 Million, Representing a 25.3% YoY Increase Form 8 K
November 6

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Catalyst Pharmaceuticals mentioned in the news?

Catalyst Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Catalyst Pharmaceuticals performing compared to its industry peers?

Catalyst Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Catalyst Pharmaceuticals in the last month?

Catalyst Pharmaceuticals' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Catalyst Pharmaceuticals?

By monitoring mentions in the news for Catalyst Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Catalyst Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Catalyst Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact